Skip to main content

Adial Pharmaceuticals Inc Warrant (ADILW)

About The Company

ADILW Stock Market Logo

Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company develops prescription medications for addiction and related disorders. Its lead product is AD04, which is for the treatment of alcohol use disorder.

IPO Year Sector Industry
2018 Health Care Biotechnology: Pharmaceutical Preparations

Adial Pharmaceuticals Inc (ADILW) Latest News

Company Contact & Address (ADILW)

Corporate Headquarters Phone Website
1180 SEMINOLE TRAIL SUITE 495,
CHARLOTTESVILLE,
Virginia,
22901,
United States
+1 434 422-9800 Official ADILW Website

ADILW Key Executives

Ownership and management information.

Key Data Points*

Exchange Not Available Market Cap Not Available
Sector Health Care P/E Ratio Not Available
Industry Biotechnology: Pharmaceutical Preparations Forward P/E 1 Yr. Not Available
1 Year Target Not Available Earnings Per Share (EPS) Not Available
Today’s High/Low Not Available Annualized Dividend Not Available
Share Volume Not Available Ex Dividend Date Not Available
Average Volume Not Available Dividend Pay Date Not Available
Previous Close Not Available Current Yield Not Available
52 Week High/Low Not Available Beta Not Available

* Information and data may delayed

Officers & Directors @ ADILW

Jobs & Employment at Adial Pharmaceuticals Inc

LinkedIn Company Page https://www.linkedin.com/company/adialpharma
Official Career & Employment Page View LinkedIn page for the employment, careers & jobs details.

Related & Similar Stock Symbols

SUAC Stock Market Price & News

SUAC

ShoulderUp Technology Acquisition Corp. Class A Common …

AJX Stock Market Price & News

AJX

Great Ajax Corp. Common Stock

CNTX Stock Market Price & News

CNTX

Context Therapeutics Inc. Common Stock